Mulugeta R

National Medicine and Food Administration, Ministry of Health, Eritrea

Publications
  • Research   
    Economic Burden of Adverse Drug Reactions among Hospitalized Patients in Eritrea: A Five-month Prospective Analysis of 5848 Patients
    Author(s): Dawit T*, Mulugeta R, Melake T, Iyassu B, Usman A and Semere G

    Many countries have been facing multiple disease burdens which have clinical, economic, and social impact; one of which is adverse drug reactions (ADRs). In the United States, for example, the annual financial burden is estimated to be USD 177.4 billion. It is well-recognized that there is a strong linkage between health and economic growth. In Eritrea,healthcare is provided by the Government of the State of Eritrea (GOE) through public hospitals, which is highly subsidized. The health policy of the GOE is ensuring access to healthcare services to all citizens in an equitable and affordable manner guided by the principle of social justice. Despite the efforts underway in the country, Eritrea is still facing newly emerging public health problems like ADRs, whose clinical, economic and social burden need to be determined. In this nationwide study, 18 hospitals (17 public and one private.. View more»

    Abstract HTML PDF